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interoperable memory devices,27 coun-
ters,27 sensors,28,29 and protein scaffolds.30 
Using these circuits, biological engineers 
have created synthetic organisms that 
can be used for bioremediation, biosens-
ing, computation, bioenergy and medi-
cal therapeutics (reviewed in ref. 31–33). 
Despite these advances, the realization of 
synthetic-biology-based applications will 
require future breakthroughs in our abil-
ity to create sufficiently complex and reli-
able biological systems. Here, I will discuss 
current limitations and potential solutions 
for the construction, probing, modulation 
and debugging of scalable biological sys-
tems as well as hurdles for the deployment 
of engineered organisms from bacteria to 
mammalian cells which adds to the dis-
cussion of next-generation synthetic gene 
networks in reference 31 (Fig. 1).
Physical Construction  
of Scalable Biological Systems
Construction of early synthetic circuits 
largely relied on restriction enzymes and 
polymerase chain reaction (PCR)-based 
techniques to assemble existing genetic 
components. These methods do not scale 
well with increasing complexity due to 
a lack of sufficient unique restriction 
sites and the need to have physical DNA 
templates from which to amplify genetic 
parts. Standards for library construction 
and the assembly of parts libraries34 have 
been integral in circumventing this depen-
dency on templates and restriction sites. 
However, since these parts must be devoid 
of restriction sites used in the defined 
standards and should ideally be optimized 
for use in one’s organism of choice,35 the 
use of whole-gene DNA synthesis is on 
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Synthetic biology is focused on engi-neering biological organisms to study 
natural systems and to provide new solu-
tions for pressing medical, industrial 
and environmental problems. At the 
core of engineered organisms are syn-
thetic biological circuits that execute the 
tasks of sensing inputs, processing logic 
and performing output functions. In 
the last decade, significant progress has 
been made in developing basic designs 
for a wide range of biological circuits 
in bacteria, yeast and mammalian sys-
tems. However, significant challenges in 
the construction, probing, modulation 
and debugging of synthetic biological 
systems must be addressed in order to 
achieve scalable higher-complexity bio-
logical circuits. Furthermore, concomi-
tant efforts to evaluate the safety and 
biocontainment of engineered organ-
isms and address public and regulatory 
concerns will be necessary to ensure that 
technological advances are translated 
into real-world solutions.
In the last century, scientists have made 
giant strides in identifying and study-
ing biological parts such as proteins and 
nucleic acids,1-5 understanding regulatory 
networks,6 and constructing engineered 
organisms using the ever-advancing tools 
of genetic engineering.7 In the last decade, 
synthetic biologists have leveraged the 
power of modern molecular biology using 
frameworks translated from traditional 
disciplines such as electrical engineering, 
computer science, mechanical engineer-
ing and chemical engineering to create a 
wide range of synthetic biological circuits, 
including switches,8-15 oscillators,16-18 digi-
tal logic gates,19-23 filters,24-26 modular and 
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what DNA to write (Fig. 2). Just as the 
decoding of the human genome sequence 
did not immediately reveal the functions 
of all human genes, the utility of high-
throughput DNA synthesis technology 
will only gradually become evident as 
synthetic biologists learn how to create 
complex systems. For example, future 
synthesized circuits should be designed 
with ease of probing, modulating and 
debugging in mind. These features could 
be implemented by including validated 
RNA “handles” that can be easily mea-
sured with standard probe sets to deter-
mine internal RNA concentrations, gene 
circuits that allow inducers to modulate 
synthetic circuit protein levels, and prop-
erly situated restriction sites for the rapid 
cloning of components that need system-
atic optimization, such as ribosome bind-
ing sequences.
Significant advances in well-charac-
terized, interoperable devices are neces-
sary for the construction of higher-order 
modules that will enable scalable biologi-
cal systems.38 The majority of biological 
circuits have been constructed using a 
handful of synthetic parts.31 Furthermore, 
it is often the case that when new designs 
for biological parts are developed, only a 
few instantiations are created and tested, 
usually in single cellular backgrounds. As 
a result, there is a need for the systematic 
DNA synthesis productivity has exceeded 
1 Mbp per person per day while Venter 
and colleagues recently succeeded in syn-
thesizing a 1.08 Mbp genome.37 However, 
most synthetic gene circuits to date have 
not exceeded the 50 Kbp level, indicating 
that there is a large gap between our abil-
ity to read and write DNA and knowing 
the rise.36 Using direct chemical synthe-
sis, circuits can be designed in silico and 
implemented in DNA with significantly 
less effort from researchers. As DNA syn-
thesis becomes increasingly economical 
and efficient, it will become possible to 
construct complex systems with less reli-
ance on restriction enzymes. For example, 
Figure 1. A basic design cycle for synthetic biology includes creating well-characterized parts (e.g., regulatory elements, genes, proteins, RNAs), con-
structing synthetic devices and modules and designing and assembling higher-order networks. All steps of this cycle are aided by modelling, probes 
and modulators to analyze circuit performance. Debugging is an iterative process based on parts optimization, fine-tuning regulatory components, 
modelling and changing circuit architecture.
Figure 2. DNA sequencing and synthesis technologies are advancing at exponential rates, 
outpacing the ability of synthetic biologists to construct useful and scalable biological circuits.36 
These trends are similar to Moore’s law for integrated circuits72 and suggest that there is substan-
tial room for growth in the field of synthetic circuits.
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can be constructed in synthetic promot-
ers and co-transformed into cells with 
all pairwise combinations of transcrip-
tion factors under independent inducible 
control. Proper NOR gate functionality 
and crosstalk can then be determined in 
a high-throughput fashion for all poten-
tial gates by varying inducer levels and 
measuring reporter gene output. In addi-
tion to enabling interoperable gate selec-
tion, large-scale experiments such as these 
should yield substantial data for models 
that can predict the orthogonality of tran-
scription factors and operators for future 
circuits (e.g., using heuristic or thermody-
namically guided algorithms). Moreover, 
matrices of cross-repression interactions 
can be constructed and incorporated into 
Then, all possible combinations of tran-
scription factor plasmids and reporter 
plasmids can be co-transformed into cells 
and tested for single-component perfor-
mance (e.g., when a transcription factor 
is co-transformed with its cognate opera-
tor site) and potential crosstalk interac-
tions (e.g., when a transcription factor is 
co-transformed with non-cognate opera-
tor sites). Standard induction curves can 
be derived by varying the concentration 
of transcription factors using the induc-
ible promoters and measuring the result-
ing output.42 Based on these results, an 
optimal set of non-interacting transcrip-
tion factors and cognate operators can be 
selected. To create the NOR gates, all pos-
sible pairwise combinations of operators 
development and characterization of 
compatible biological parts. Specificity 
in biological systems largely relies on 
spatial distribution and chemical interac-
tions. This is in stark contrast to electrical 
engineering, where specificity is achieved 
through direct electrical wiring. Thus, 
strategies for achieving inter-part com-
patibility include targeting circuits to 
isolated compartments,39,40 mutagenesis 
and directed evolution of existing parts, 
and using comparative genomics to iden-
tify, synthesize, and test homologous pro-
teins or nucleic acids. These efforts may 
be complicated by unknown global fac-
tors (e.g., growth rates, endogenous tran-
scription factors with off-target effects on 
synthetic circuits, protein-protein inter-
actions, small RNAs) that can confound 
device testing and render it difficult to 
use pre-defined parts in a wide range of 
organisms and environmental conditions 
without additional alterations and char-
acterization.41 Therefore, combinatorial 
methods to test single-component perfor-
mance, multi-component interactions and 
biological crosstalk (e.g., cross-activation 
or cross-repression of transcription, non-
specific enzymatic activity, inappropriate 
triggering of signalling pathways) will 
be important for parts libraries (Fig. 3). 
These results should be incorporated into 
mathematical models to aid future model-
based design. Indeed, institutions such 
as BIOFAB are attempting to systemati-
cally assemble and characterize libraries 
of synthetic devices. However, develop-
ment efforts for certain platforms that are 
promising for library construction, such as 
zinc finger proteins and RNA interference, 
may be slowed by the presence of existing 
intellectual property.43
As an example of combinatorial char-
acterization (Fig. 3), suppose one would 
like to construct multiple interoperable 
NOR (NOT-OR) gates to constitute a 
universal logic system. NOR function-
ality can be built by placing pairwise 
combinations of unique operator sites for 
transcriptional repressors within synthetic 
promoters. To identify orthogonal repres-
sors, one can encode individual transcrip-
tion factors under inducible control on 
one set of plasmids and individual cog-
nate operator sites driving expression of a 
reporter gene on another set of plasmids. 
Figure 3. Combinatorial high-throughput methods will be useful in the assembly of well-char-
acterized libraries of synthetic parts and devices. For example, transcriptional regulators and 
their cognate inducers can be analyzed for (A) single-component performance, (B) interactions 
between multiple components and (C) inducer crosstalk (e.g., cross-activation and/or cross-
inhibition).
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microscopy can now achieve frequency 
modulation of inputs and long time-scale 
data collection necessary for frequency-
domain analysis.45,47 Furthermore, micro-
fluidics devices can be coupled with 
electronic controllers to stabilize and 
alter the dynamics of synthetic biologi-
cal circuits similar to electronic control-
lers that are used to control mechanical 
systems. The insights that can be gained 
from linearized block models of complex 
systems can complement the accuracy 
of time-domain state-space representa-
tion, time-based mathematical simu-
lations and non-linear control theory. 
To enable successful time-based and 
frequency-based modelling of biological 
systems, accurate parameters will need to 
be derived by high-throughput in vitro 
real-time electronic models of synthetic 
biological systems.44 Other techniques 
from control theory such as small-signal 
linearization and modularization enable 
tractable modelling and simulations 
prior to implementation. Biological sys-
tems exhibit nonlinearity (e.g., coop-
erativity) which can be linearized in 
different regions of operation (Fig. 4A). 
Frequency-domain analysis in linearized 
systems allows for block modelling and 
deeper understanding of system dynam-
ics, such as noise, stability, time con-
stants and performance (Fig. 4B).45,46 
Small-signal linearization and frequency-
domain modelling have not been exten-
sively used for studying and designing 
synthetic biological circuits even though 
advances in microfluidics and time-lapse 
transcriptional models when cross-inter-
acting transcription factors must be used 
in other systems.
Model-guided design is crucial for 
the construction of complicated electri-
cal and mechanical systems. Time-based 
simulations for electrical and mechanical 
systems are possible since mathematical 
models are established and parameters 
are well known. In contrast, most param-
eters in biological circuits are unknown 
and the computational resources required 
to accurately simulate noise and multiple 
component interactions are significant. 
Recent advances in modelling chemical 
networks, transcription, translation and 
biological noise using the inherent phys-
ics of solid-state electronic devices should 
enable the construction of large-scale 
Figure 4. Control theory techniques for modelling synthetic biological circuits. (A) Small-signal linearization of biological components in different 
regions of operation enables the development of linear models. (B) Linearization can enable frequency-domain analysis, systems modelling using 
block diagrams and deeper insights into system dynamics. For example, transcription and translation can be understood as low-pass filters and block 
diagrams can be drawn for simple negative-feedback loops to yield understanding into system interconnections and responses to different input 
types.45,46 In the block diagram shown, s refers to jω where j is √-1 and ω is angular frequency.
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design of sequence-specific modulators. 
However, RNAi is not available in many 
organisms of interest and must be coupled 
with efficient delivery mechanisms for 
nucleic acids.19 Fortunately, RNAi has 
been reconstituted in well-studied organ-
isms such as Saccharomyces cerevisiae and 
significant advances are being made in 
RNAi-delivery technology.56
Debugging Malfunctioning  
Biological Systems
The harsh reality of engineering synthetic 
biological circuits is that most designs 
fail to perform as expected. Debugging 
of synthetic circuits is a painstakingly 
iterative process involving the detailed 
characterization of all available inter-
nal nodes, trial-and-error modification 
of constituent components and model-
ling. However, debugging will be greatly 
facilitated by improved techniques for 
sequencing, probing and modulating 
synthetic circuits, as described above. 
For example, an initial debugging step 
is usually to fully sequence all circuit 
components to ensure that the intended 
genetic program has been constructed. 
Subsequent debugging can include 
dynamically probing all possible RNA 
and protein nodes and interactions using 
techniques such as qRT-PCR, fluores-
cent protein fusions and circuit-specific 
methods (e.g., in vitro gel shift assays, 
protein phosphorylation assays, single-
cell microscopy, and so forth). Based on 
these results, it can often be determined 
whether system failure is due to inher-
ent circuit topology or due to poor com-
ponent performance leading to circuit 
operation in non-functional parameter 
regions. In the former case, redesigns 
are needed and can benefit from detailed 
modelling using insights and measure-
ments from the failed attempts. In the 
latter case, systematic and randomized 
mutagenesis and screening techniques are 
helpful to optimize system performance. 
For example, synthetic circuits often do 
not work properly because of mismatched 
expression levels resulting in outputs that 
do not fit into the dynamic range of other 
inputs. Mismatches in dynamic range 
can usually be corrected by systemati-
cally altering the strengths of promoters 
protein levels. Multiplexed RNA levels 
can be assayed with qRT-PCR or microar-
rays but these techniques require nucleic 
acid extraction and cellular destruction. 
Fusing RNAs of interest to aptamers that 
bind fluorescent proteins or fluorescent 
small molecules can be used to monitor in 
vivo RNA levels but requires modifying 
RNAs of interest.48 Side-by-side fluores-
cence resonance energy transfer (FRET) 
probes, quenched autoligation probes and 
molecular beacons are sequence-specific 
tools for detecting RNA levels in vivo 
with multiplexing capabilities but face 
challenges such as intracellular delivery, 
compartmentalization and degradation.48 
Nonetheless, nucleic-acid-based probes 
are likely to be early enablers for high-
throughput in vivo monitoring of tran-
scription in synthetic biological circuits 
given that they are relatively easy to design 
for different targets. Thus, methods for 
achieving efficient delivery of nucleic-
acid-based probes are crucially needed 
to make them widely useful to synthetic 
biologists for monitoring in vivo RNA lev-
els in real time.
The majority of modulators used in 
synthetic circuits today are small mol-
ecules that induce or repress the activ-
ity of existing transcriptional regulators. 
As increasing number of transcriptional 
regulators are identified or created, it will 
be important to identify corresponding 
inducers that can control in vivo func-
tion, characterize crosstalk between dif-
ferent inducers and design interoperable 
modulators. For example, directed evolu-
tion of the AraC transcriptional regulator 
was necessary to increase compatibility 
between arabinose-controlled and IPTG-
controlled systems.53 Other modulators 
for synthetic circuits include aptamers 
that respond to small molecules and trig-
ger translational activities.29 These aptam-
ers can be discovered using techniques 
such as Systematic Evolution of Ligands 
by Exponential Enrichment (SELEX). 
Light-inducible proteins provide rapid 
and well-controlled signal transduc-
tion that could potentially be enhanced 
by developing variants which preferen-
tially respond to different wavelengths 
of light.54,55 An underutilized technology 
in synthetic biology is RNA interference 
(RNAi), which allows straightforward 
and in vivo probes and microarrays, as 
described below.
Molecular Probes and Modulators 
for Scalable Biological Systems
High-throughput methods for probing 
multiple nodes, such as protein and RNA 
levels, in complex biological circuits are 
necessary to achieve reliable and scal-
able performance.48 Ideal probe features 
include high signal-to-noise ratios, speci-
ficity, low cost, multiplexability, non-inva-
siveness and the ability to reveal real-time 
dynamics. Complementary techniques 
for the reliable and multiplexed modula-
tion of synthetic circuits are also needed 
to generate perturbations to obtain system 
parameters, drive accurate models and 
monitor system performance.
Analyses of most synthetic circuits rely 
on fluorescent proteins, which are well-
characterized, easy to detect and can be 
multiplexed, as reporters of combined 
transcriptional and translational activity. 
However, fluorescent proteins are large, 
require folding and maturation and can be 
too stable to track rapid dynamics with-
out additional modifications.49 To address 
these issues, methods have recently been 
developed to create fast-folding fluores-
cent proteins, degradation tags and in 
vivo ligation of fluorophores to proteins.50 
Alternative methods for monitoring pro-
tein levels in synthetic circuits include 
luminescence or colorimetric assays 
although these methods can be more 
difficult to multiplex. Advances in high-
throughput proteomic characterization 
may eventually enable global monitoring 
of protein levels across time without the 
need for multiplexed reporter proteins.51 
Nucleic-acid aptamer beacons may also 
play a role in protein detection but have 
not been extensively applied to in vivo set-
tings and require selection protocols since 
there are no algorithms that can reliably 
predict the affinity of binding between 
aptamers and proteins of interest.52 Thus, 
new techniques for multiplexed and global 
protein detection are needed for scalable 
biological system design.
Transcriptional activity can be moni-
tored by quantifying RNA in engineered 
cells, which is easier to do in a multiplexed 
and global fashion than quantifying 
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methods to eliminate engineered organ-
isms as needed,70 stringent techniques to 
evaluate safety in animals and humans, 
techniques for encapsulating and isolat-
ing engineered cells,71 assays for mutation 
rates in deployed organisms, utilization of 
probiotic strains as substrates for engineer-
ing microbe-based therapeutics and close 
communication with regulatory agencies 
will be necessary to translate synthetic bio-
logical organisms into the important fron-
tier of human treatments. Furthermore, 
synthetic biologists interested in human 
therapeutics should focus their efforts on 
areas of significant unmet need to opti-
mize risk-benefit tradeoffs and should be 
open to proof-of-concept applications in 
areas with lower regulatory hurdles such 
as environmental or veterinary use.
Conclusions
The past decade has delivered significant 
advances in the design and construction of 
basic synthetic circuits. In the upcoming 
decade, novel technologies for compos-
ing, probing, modulating and debugging 
scalable biological circuits will enable the 
robust performance of useful tasks by 
engineered organisms. Scientific advance-
ments must be accompanied by con-
comitant efforts to address societal and 
regulatory concerns over synthetic biol-
ogy. These endeavors should yield exciting 
new solutions for real-world problems in 
critical areas of medical, industrial, envi-
ronmental and energy applications.
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